
OGT 2115
CAS No. 853929-59-6
OGT 2115( —— )
Catalog No. M33446 CAS No. 853929-59-6
OGT 2115 is an inhibitor of heparanase (IC50 = 0.4 μM), an enzyme that cleaves heparan sulfate into glucuronic acid (GlcUA) and N-acetylglucosamine (GlcNAc).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 46 | Get Quote |
![]() ![]() |
5MG | 67 | Get Quote |
![]() ![]() |
10MG | 119 | Get Quote |
![]() ![]() |
25MG | 250 | Get Quote |
![]() ![]() |
50MG | 419 | Get Quote |
![]() ![]() |
100MG | 605 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameOGT 2115
-
NoteResearch use only, not for human use.
-
Brief DescriptionOGT 2115 is an inhibitor of heparanase (IC50 = 0.4 μM), an enzyme that cleaves heparan sulfate into glucuronic acid (GlcUA) and N-acetylglucosamine (GlcNAc).
-
DescriptionOGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number853929-59-6
-
Formula Weight495.3
-
Molecular FormulaC24H16BrFN2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 11.36 mg/mL (22.94 mM; Ultrasonic )
-
SMILESOC(=O)Cc1ccc2oc(nc2c1)-c1ccc(NC(=O)\C=C\c2ccc(Br)cc2)c(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15(9):2295-9.?
molnova catalog



related products
-
SNAP-25 187-203
This amino acids187 to 203 fragment is derived from the C-terminal helix of synaptosomal-associated protein of 25 kDa (SNAP-25). This peptide is able to rescue exocytosis from botulinum neurotoxin E (BoNT/E)-treated cells, albeit at higher concentrations than the full-length coil.
-
Etilefrine pivalate ...
Etilefrine pivalate HCl is an orally active compound for the treatment of migraine headaches.
-
Sagittatoside A
Sagittatoside A selectively activates estrogen response element (ERE)-luciferase activity via ERα.